SNDX — Syndax Pharmaceuticals Inc · rev $137.7M

Syndax Pharmaceuticals Inc (SNDX) is a biotechnology company listed on US.

Latest reported SNDX revenue for 2026-06-30 was $137.7M. Net income was -$92.0M. SNDX currently screens at market cap $774.4M.

Use this SNDX page for company research — sector, financials, and the latest filing takeaway — not a live tape. The session quote (last, range, volume) lives on the SNDX quote page. Cached 10-K, 10-Q, 8-K, and Form 4 exhibits are on the SNDX SEC filings page. Lician reads the product cache first so this HTML stays unique to Syndax Pharmaceuticals Inc even when a live quote feed is slow.